Skip to content
The Policy VaultThe Policy Vault

OfevMedical Mutual

Interstitial Lung Disease Associated with Systemic Sclerosis

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Forced vital capacity is ≥ 40% of the predicted value; AND
  • Diagnosis is confirmed by high-resolution computed tomography; AND
  • Medication is prescribed by or in consultation with a pulmonologist or a rheumatologist

Reauthorization criteria

  • Patient is age ≥ 18 years; AND
  • Patient has experienced a beneficial response to therapy over the last year while receiving Ofev (if < 1 year, response is from baseline prior to initiating Ofev); AND
  • Medication is prescribed by or in consultation with a pulmonologist or a rheumatologist

Approval duration

1 year